. Author manuscript; available in PMC: 2015 Dec 8.

Published in final edited form as: J Appl Stat. 2014 Jun 9;41(12):2676–2695. doi: 10.1080/02664763.2014.925102

Table 2.

Patient-specific meta-analysis estimates of log cumulative hazard and risk of distant recurrence at 10 years. Hypothetical patients of age 60.

Tumor grade	Tumor size (cm)	RS	NSABP B-14		TransATAC		Patient-specific meta-analysis
Tumor grade	Tumor size (cm)	RS	Log cumulative hazard estimate (variance)	Meta-analysis weight	Log cumulative hazard estimate (variance)	Meta-analysis weight	Log cumulative hazard estimate (variance)	Risk estimate (95% CI)
Well	2	24	−2.179 (0.076)	60.8%	−2.390 (0.117)	39.2%	−2.262 (0.046)	9.9% (6.6%, 14.7%)
Well	4	40	−1.447 (0.112)	60.1%	−0.846 (0.169)	39.9%	−1.207 (0.067)	25.9% (16.5%, 39.2%)
Moderate	2	9	−2.841 (0.070)	42.4%	−2.520 (0.051)	57.6%	−2.656 (0.030)	6.8% (4.9%, 9.4%)
Poor	4	40	−0.401 (0.051)	58.8%	0.061 (0.073)	41.2%	−0.211 (0.030)	55.5% (43.8%, 68.0%)
Poor	0.5	40	−1.226 (0.071)	44.5%	−1.836 (0.057)	55.5%	−1.565 (0.031)	18.9% (13.7%, 25.6%)
Poor	4	9	−1.525 (0.105)	50.8%	−1.014 (0.108)	49.2%	−1.273 (0.053)	24.4% (16.3%, 35.6%)

Note: Hypothetical patients of age 60.